1Assistant Professor, Department of Physiology, Ponnaiyah Ramajayam Institute of Medical Sciences, Manamai-Nallur, Kancheepuram District, ECR, Chennai
2Associate Professor, Bharati Vidyapeeth Deemed University Medical College, Satara Road, Pune
*Corresponding author: Dr. Anuradha Joshi, Associate Professor, Bharati Vidyapeeth Deemed University Medical College, Satara Road, Pune-411043
Online published on 16 July, 2018.
The prevalence of diabetes is rapidly rising all over the globe at an alarming rate1. Complications of diabetes include microvascular and macrovascular complications2, 3. High sensitivity C-reactive protein (hsCRP) is an acute phase reactant and a sensitive marker of inflammation. In addition to traditional cardiovascular risk factors, elevation in hsCRP can be used to predict increased cardiovascular risk in diabetic patients4.
HsCRP, Fasting Blood Glucose, Diabetes Mellitus